Literature DB >> 11739090

Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation.

T Alp Ikizler1, Lara B Pupim, John R Brouillette, Deanna K Levenhagen, Kali Farmer, Raymond M Hakim, Paul J Flakoll.   

Abstract

The hemodialysis (HD) procedure has been implicated as a potential catabolic factor predisposing the chronic HD (CHD) patients to protein calorie malnutrition. To assess the potential effects of HD on protein and energy metabolism, we studied 11 CHD patients 2 h before, during, and 2 h after HD by use of primed constant infusion of L-[1-13C]leucine and L-[ring-2H5]phenylalanine. Our results showed that HD led to increased whole body (10%) and muscle protein (133%) proteolysis. Simultaneously, whole body protein synthesis did not change, and forearm synthesis increased (120%). The net result was increased net whole body protein loss (96%) and net forearm protein loss (164%). During the 2-h post-HD period, the muscle protein breakdown trended toward baseline, whereas whole body protein breakdown increased further. Substrate oxidation during the post-HD was significantly altered, with diminished carbohydrate and accelerated lipid and amino acid oxidation. These data demonstrate that hemodialysis is an overall catabolic event, decreasing the circulating amino acids, accelerating rates of whole body and muscle proteolysis, stimulating muscle release of amino acids, and elevating net whole body and muscle protein loss.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739090     DOI: 10.1152/ajpendo.2002.282.1.E107

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  50 in total

1.  Malnutrition: a frequent misdiagnosis for hemodialysis patients.

Authors:  William E Mitch
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 2.  Nutritional management of patients with urea cycle disorders.

Authors:  R H Singh
Journal:  J Inherit Metab Dis       Date:  2007-11-25       Impact factor: 4.982

Review 3.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

Review 4.  Optimal nutrition in hemodialysis patients.

Authors:  T Alp Ikizler
Journal:  Adv Chronic Kidney Dis       Date:  2013-03       Impact factor: 3.620

Review 5.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

6.  Pulmonary hypertension in end-stage renal disease and post renal transplantation patients.

Authors:  Esam H Alhamad; Mohammed Al-Ghonaim; Hussam F Alfaleh; Joseph P Cal; Nazmi Said
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

7.  Some amino acids levels: glutamine,glutamate, and homocysteine, in plasma of children with chronic kidney disease.

Authors:  Fatina I Fadel; Manal F Elshamaa; Rascha G Essam; Eman A Elghoroury; Gamila S M El-Saeed; Safinaz E El-Toukhy; Mona Hamed Ibrahim
Journal:  Int J Biomed Sci       Date:  2014-03

8.  Glucocorticoid-Regulated Kinase: Linking Azotemia and Muscle Wasting in CKD.

Authors:  Madhav C Menon; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2016-04-08       Impact factor: 10.121

Review 9.  Intradialytic parenteral nutrition in end-stage renal disease: practical aspects, indications and limits.

Authors:  Alice Sabatino; Giuseppe Regolisti; Elio Antonucci; Aderville Cabassi; Santo Morabito; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2014-02-21       Impact factor: 3.902

Review 10.  New insights into the role of anabolic interventions in dialysis patients with protein energy wasting.

Authors:  Jie Dong; T Alp Ikizler
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.